Pharmacological investigations of some bis-quaternary ammonium salts of NN-bis-(aminoacylo)piperazine derivatives. II. Influence on cholinergic system, cholinesterase activity and histamine liberation.
D000110:Acetylcholinesterase / Q000378:metabolism*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000201:enzymology*; D002415:Cats; D002802:Cholinesterases / Q000097:blood*; D005725:Ganglia, Autonomic / Q000187:drug effects; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D006636:Histamine Release; D006801:Humans; D066298:In Vitro Techniques; D009132:Muscles / Q000494:pharmacology*; D010477:Perfusion; D010830:Physostigmine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D014403:Tubocurarine / Q000494:pharmacology; D014630:Vagus Nerve / Q000502:physiology
D010879:Piperazines; D000644:Quaternary Ammonium Compounds; D001285:Atropine; D010830:Physostigmine; D000110:Acetylcholinesterase; D002802:Cholinesterases; D014403:Tubocurarine